Induction of pluripotent cells
    5.
    发明授权

    公开(公告)号:US12195762B2

    公开(公告)日:2025-01-14

    申请号:US17320676

    申请日:2021-05-14

    Abstract: The slow kinetics and low efficiency of reprogramming methods to generate human induced pluripotent stem cells (iPSCs) impose major limitations on their utility in biomedical applications. Here we describe a chemical approach that dramatically improves (>200 fold) the efficiency of iPSC generation from human fibroblasts, within seven days of treatment. This will provide a basis for developing safer, more efficient, non-viral methods for reprogramming human somatic cells.

    Reprogramming cells
    6.
    发明授权

    公开(公告)号:US10738281B2

    公开(公告)日:2020-08-11

    申请号:US16239452

    申请日:2019-01-03

    Abstract: The present invention provides for methods, compositions, and kits for producing an induced pluripotent stem cell from a non-pluripotent mammalian cell using a 3′-phosphoinositide-dependent kinase-1 (PDK1) activator or a compound that promotes glycolytic metabolism as well as other small molecules.

    Reprogramming cells
    8.
    发明授权

    公开(公告)号:US10214729B2

    公开(公告)日:2019-02-26

    申请号:US15489600

    申请日:2017-04-17

    Abstract: The present invention provides for methods, compositions, and kits for producing an induced pluripotent stem cell from a non-pluripotent mammalian cell using a 3′-phosphoinositide-dependent kinase-1 (PDK1) activator or a compound that promotes glycolytic metabolism as well as other small molecules.

Patent Agency Ranking